Phloretin

Phloretin

SCHEMBL38131

O=C(CCc1ccc(O)cc1)c1c(O)cc(O)cc1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC5A1 P13866 7/20 1.00
SLC5A2 P31639 7/20 1.00
CYP19A1 P11511 4/20 1.00
MAPT P10636 3/20 1.00
HSD17B10 Q99714 3/20 1.00
GAA P10253 2/20 1.00
NFKB1 P19838 2/20 1.00
NFKB2 Q00653 2/20 1.00
RELA Q04206 2/20 1.00
SLC28A3 Q9HAS3 2/20 1.00
KDM4E B2RXH2 2/20 1.00
CYP3A4 P08684 2/20 1.00
THRB P10828 2/20 1.00
CYP2C9 P11712 2/20 1.00
HPGD P15428 2/20 1.00
CYP2C19 P33261 2/20 1.00
MEN1 O00255 1/20 1.00
SLC16A3 O15427 1/20 1.00
ALDH1A1 P00352 1/20 1.00
LMNA P02545 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phloretin SCHEMBL1506325 1.00 SLC5A1 (1.00) SLC5A1SLC5A2CYP19A1MAPTHSD17B10
Phloretin SCHEMBL31684375 0.98 SLC5A1 (0.96) SLC5A1SLC5A2CYP19A1MAPTHSD17B10
Phloretin SCHEMBL30912872 0.98 SLC5A1 (0.96) SLC5A1SLC5A2CYP19A1MAPTHSD17B10
Phloretin SCHEMBL30785809 0.98 SLC5A1 (0.96) SLC5A1SLC5A2CYP19A1MAPTHSD17B10
Phloretin SCHEMBL27910960 0.96 SLC5A1 (0.93) SLC5A1SLC5A2CYP19A1MAPTHSD17B10
Phloretin SCHEMBL28362318 0.93 SLC5A1 (0.87) SLC5A1SLC5A2CYP19A1MAPTHSD17B10
Phloretin SCHEMBL30603791 0.93 SLC5A1 (0.87) SLC5A1SLC5A2CYP19A1MAPTHSD17B10
Phloretin SCHEMBL21192491 0.93 SLC5A1 (0.87) SLC5A1SLC5A2CYP19A1MAPTHSD17B10
Phloretin SCHEMBL6402644 0.93 SLC5A1 (0.87) SLC5A1SLC5A2CYP19A1MAPTHSD17B10
Phloretin SCHEMBL27906064 0.93 SLC5A1 (0.87) SLC5A1SLC5A2CYP19A1MAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 9048 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747367-A1 NEW ENZYMES FOR THE MANUFACTURING OF 4'-O-METHYLATED PHENOLIC SUBSTANCES Symrise AG (DE) 2026-05-27 EP claimed
CN-122074552-A Liquid preservative for preserving fresh walnut kernels 2026-05-26 CN claimed
CN-122031436-A Application of phloretin in preparation of medicament for improving muscular atrophy 南京大学 2026-05-15 CN claimed
CN-122031336-A Whitening and freckle-removing composition based on multi-channel synergy and application thereof 广州诺彦生物科技有限公司 2026-05-15 CN claimed
CN-122012432-A Phloretin enzyme activity related protein, and coding gene and application thereof 中国中医科学院中药研究所 2026-05-12 CN claimed
US-20260069523-A1 SKIN CARE COMPOSITION AND USE THEREOF NANJING NUTRABUILDING BIO TECH CO LTD (CN) 2026-03-12 US claimed
EP-4704600-A1 DAIRY BEVERAGES WITH IMPROVED TASTE The Coca-Cola Company (US) 2026-03-11 EP claimed
EP-4704601-A1 DAIRY-ALTERNATIVE BEVERAGES WITH IMPROVED TASTE The Coca-Cola Company (US) 2026-03-11 EP claimed
EP-4701427-A1 THERMAL ENERGY SYSTEM FOR ADMINISTERING ACTIVE AGENTS UltraOral Ltd. (IL) 2026-03-04 EP claimed
US-20260048027-A1 METHYLATED PHLORETIN ANALOGS AS INHIBITORS OF SGLT2 NESTLE SA (CH) 2026-02-19 US claimed
WO-1992006685-A1 ENHANCEMENT OF CELLULAR ACCUMULATION OF LIPOPHILIC CATIONIC ORGANOMETALLIC COMPOUNDS BY REDUCTION OF INTRAMEMBRANE POTENTIAL BRIGHAM AND WOMEN'S HOSPITAL (US) 1992-04-30 WO claimed
EP-0445255-A1 TREATMENT OF CONDITIONS AND DISEASE. NORPHARMCO INC (CA) 1991-09-11 EP claimed
CN-1051503-A Disease and treatment of diseases NORPHARMCO INC (CA) 1991-05-22 CN claimed
WO-1991004058-A2 TREATMENT OF CONDITIONS AND DISEASE NORPHARMCO INC. (CA) 1991-04-04 WO claimed
US-4959355-A GLUCOSE TRANSPORT BLOCKER THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 1990-09-25 US claimed
US-4840939-A Treatment of cancer with phlorizin and its derivatives LEVEEN HARRY H (US) 1989-06-20 US claimed
EP-0292576-A1 ANTI-ULCEROUS AGENT CONTAINING CHALCONE DERIVATIVE AS EFFECTIVE INGREDIENT AND NOVEL CHALCONE DERIVATIVES TSUMURA & CO. (JP) 1988-11-30 EP claimed
EP-0291151-A1 Compositions comprising phlorizin derivatives for treatment of cancer Leveen, Harry H. (US) 1988-11-17 EP claimed
US-4219569-A CARBOCYCLIC KETONES THE UPJOHN COMPANY (US) 1980-08-26 US claimed
US-3977944-A Enzyme-kinetic determination of the concentration of a substrate EPPENDORF GERATEBAU NETHELER & HINZ GMBH (DT) 1976-08-31 US claimed